Recently, the alteration of CD169 and HLA-DR expression in monocytes and inflammation indices in COVID-19 patients upon different waves of the pandemic and their persistence in PASC individuals were also observed[91]. This evidence concerns the gene SIGLEC1 and COVID-19.